GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial ...
Smithsonian Magazine on MSN
Horseshoe Crab Blood Has Long Helped Us Make Safe Medicines. Now, Alternatives That Spare the Ancient Creatures Might Be Breaking Through
An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...
HealthDay on MSN
Two-Dose Recombinant Zoster Vaccine Effective in Older Adults, Regardless of Prior Vaccination
Two doses of the recombinant zoster vaccine are effective in older adults, including immunocompromised adults.
Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu ...
CSL ( ASX: CSL) cut its fiscal 2026 guidance for revenue and net profit after tax before amortization growth to 3% and 6% at ...
Ted Jin, founder and CEO of AuX Labs, is leading a charge in the food technology space with a mission driven by global impact ...
A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The study found ...
Savara Inc. (NASDAQ:SVRA) is one of the best stocks under $5 with highest upside potential. On October 23, Citizens JMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback